Haruko Hayasaka

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Diabetic Nephropathy

High Fat Diet Induced

Regulatory T Cells

Top Venues

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Keiko Tanaka, Haruko Hayasaka, Taiji Matsusaka
Dach1 is essential for maintaining normal mature podocytes. PloS one 19 (5) (2024)
Keiko Tanaka, Haruko Hayasaka, Taiji Matsusaka
Dach1 is essential for maintaining normal mature podocytes. PloS one 19 (5) (2024)
Keiko Tanaka, Haruko Hayasaka, Taiji Matsusaka
Dach1 is essential for maintaining normal mature podocytes. PloS one 19 (5) (2024)
Ryota Hayashi, Hayato Nakatani, Hinami Kawahata, Ryonosuke Fujie, Kaoru Kurowarabe, Haruko Hayasaka
Firefly luciferase-based chronological measurement of effector CD8 + T-cell activity using a multi-chamber luminometer. Bioanalysis (2023)
Ryota Hayashi, Hayato Nakatani, Hinami Kawahata, Ryonosuke Fujie, Kaoru Kurowarabe, Haruko Hayasaka
Firefly luciferase-based chronological measurement of effector CD8 + T-cell activity using a multi-chamber luminometer. Bioanalysis 14 (22) (2023)
Masatsune Tsujioka, Keisuke Miyazawa, Masaki Ohmuraya, Yoichi Nibe, Tetsuya Shirokawa, Haruko Hayasaka, Tsunekazu Mizushima, Takeshi Fukuma, Shigeomi Shimizu
Identification of a novel type of focal adhesion remodelling via FAK/FRNK replacement, and its contribution to cancer progression. Cell death & disease 14 (4) (2023)
Megumi Miyamoto, Yuki Kawato, Ryonosuke Fujie, Kaoru Kurowarabe, Kakeru Fujiwara, Reika Nobusawa, Ryota Hayashi, Kei Iida, Izumi Ohigashi, Haruko Hayasaka
CCL21-Ser expression in melanoma cells recruits CCR7 + naïve T cells to tumor tissues and promotes tumor growth. Cancer science (2023)
Ryota Hayashi, Hayato Nakatani, Hinami Kawahata, Ryonosuke Fujie, Kaoru Kurowarabe, Haruko Hayasaka
Firefly luciferase-based chronological measurement of effector CD8 + T-cell activity using a multi-chamber luminometer. Bioanalysis 14 (22) (2023)
Haruko Hayasaka, Junichi Yoshida, Yasutaka Kuroda, Akihiro Nishiguchi, Michiya Matsusaki, Kei Kishimoto, Hitoshi Nishimura, Mari Okada, Yuki Shimomura, Daichi Kobayashi, Yoshihito Shimazu, Yuji Taya, Mitsuru Akashi, Masayuki Miyasaka
CXCL12 promotes CCR7 ligand-mediated breast cancer cell invasion and migration toward lymphatic vessels. Cancer science 113 (4) (2022)